Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1696 of 6351
-
New hope for prostate cancer: extended radioactive therapy shows promise
Disease control Recruiting nowThe purpose of the study is to assess and evaluate dosimetry, safety, and tolerability following administration of up to 12 cycles of (177Lu) vipivotide tetraxetan (also referred to as \[177Lu\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereafter identified as AAA617) in taxane-naïve adul…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Engineered immune cells take on Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis is a single site, open label, Phase 1 study using a 3 + 3 dose escalation design in two cohorts of adults with recurrent, platinum-resistant ovarian tumors.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Video games prescribed? new study tests fun rehab for kids with cerebral palsy
Symptom relief Recruiting nowChildren with cerebral palsy (CP) often face challenges with balance, movement, and skills such as memory, problem-solving, and attention. These difficulties can affect not only daily activities but also their quality of life. Rehabilitation usually focuses on physical therapy, b…
Sponsor: Nataliya Hrabarchuk • Aim: Symptom relief
Last updated Jun 26, 2026 13:44 UTC
-
New mRNA vaccine takes aim at RSV in early human trial
Vaccine OngoingThe study will evaluate the safety, tolerability, and immunogenicity of 3 dose levels of IN006 in healthy adults aged 18 Years and Above; of a revaccination of IN006 given approximately 12 months after the initial vaccination in older adults (aged ≥60 years).
Phase 1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 12:03 UTC
-
Can a phone app curb HIV and drug use in homeless teens?
Prevention Recruiting nowThe purpose of this study is to determine whether Motivating Youth to Reduce Infections, Disconnections, and Emotion dysregulation (MY-RIDE) decreases substance use , to determine whether MY-RIDE increases human immunodeficiency virus (HIV) prevention strategies and to evaluate M…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
One shot for two viruses: combo Flu-COVID vaccine enters human testing
Vaccine CompletedThis study will evaluate the reactogenicity, safety, and immune response of Flu Seasonal/SARS-CoV-2 mRNA (mRNA Flu/COVID-19) combination vaccine. The flu portion will target multiple strains of the flu virus, while the COVID-19 part will focus on the spike protein of the SARS-CoV…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 26, 2026 15:41 UTC
-
New radiation technique aims to shrink spine tumors with fewer side effects
Symptom relief Recruiting nowTo learn about the safety of a procedure called cord dose escalated spine stereotactic radiosurgery (CDE-SSRS) in patients with MESCC.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
One size Doesn't fit all: new trial tests tailored blood thinners for joint replacement patients
Disease control Recruiting nowAfter hip or knee replacement all patients receive a standardized treatment with blood thinners, this medication is called thrombosis prophylaxis. However, despite this standard treatment some individuals still develop venous thrombosis (VTE), while others experience bleeding. Th…
Phase 4 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New strategy aims to boost HIV viral suppression in young people
Disease control Recruiting nowAlthough there have been advances in antiretroviral treatment (ART) for HIV, adolescents and young adults living with HIV (AHIV) continue to have disparate HIV outcomes particularly viral suppression (VS), when compared to other populations likely related to multi-layered challen…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tracks bone safety of DMD drug vamorolone over years
Disease control OngoingThis study aims to assess safety and effectivness of long-term treatment with vamorolone in boys with Duchenne Muscular Dystrophy (DMD) who have completed prior studies with vamorolone.
Phase 4 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can 16 years of birth records reveal how to save more newborns?
Knowledge-focused OngoingThe objective of this observational study is to analyze the factors associated with neonatal morbidity and mortality in three hospitals in Quito, Ecuador, from January 2008 to June 2024. The primary question to be addressed is: What perinatal factors are associated with neonatal…
Sponsor: HOSPITAL GINECO OBSTETRICO ISIDRO AYORA • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can a dental compass cut radiation and improve TMJ splints?
Disease control Recruiting nowThis study is being performed to determine if the use of the Dental Compass Articular and its software will produce therapeutic splints for TMD accurately and successfully, compare favorably with a cohort treated without the Dental Compass (for number of visits, splint modificati…
Sponsor: Dr. Dean Reeves Clinic • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Bladder drug repurposed to fight ALS in new trial
Disease control Recruiting nowAmyotrophic lateral sclerosis (ALS) is a progressive neurological disorder characterized by selective death of upper and lower motor neurons, which leads to severe disability and fatal outcomes. One of the major hallmarks of ALS is the denervation of neuromuscular junctions (NMJs…
Phase 2 • Sponsor: Oliver Blanchard • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
New 'Smart' immune therapy takes on lupus and arthritis
Disease control Recruiting nowThis study is an open-label, multiple-dose escalation, Investigator-Initiated Trial (IIT) clinical trial designed to evaluate the safety and tolerability of CC312 in adult patients with relapsed and refractory autoimmune diseases. The trial also assesses pharmacokinetics (PK) and…
Early phase 1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Jun 26, 2026 18:43 UTC
-
New cancer drug M3554 targets tough tumors in first human trial
Disease control Recruiting nowThe purpose of this study is to establish the recommended doses and further evaluate the safety and preliminary antitumor activity of M3554 in participants with soft tissue sarcoma (STS) and glioblastoma, IDH-wildtype. Study details include: Study Duration per participant: Appr…
Phase 1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New combo aims to boost existing cancer Drug's power
Disease control Recruiting nowResearchers are looking for a better way to treat people who have advanced solid cancers with a KRASG12C mutation. Sotorasib is a drug that targets cancer cells which contain mutated KRASG12C protein; it can stop the cancer cells from growing and can lead to their death. Sotoras…
Phase 1 • Sponsor: Bayer • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New study aims to shield transplant patients from deadly fungal infections
Disease control Recruiting nowPatients receiving an allogeneic hematopoietic stem cell transplant (allo-CSH) are at high risk of infection, particularly of fungal origin. Until the 2018 recommendations of the 6th European Conference on Infections in Leukemia (ECIL6), primary prophylaxis of invasive fungal inf…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
AI reads your Heart's electrical signals to spot hidden valve trouble
Diagnosis Recruiting nowTwo recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% an…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients
Disease control Recruiting nowThis research study is a phase Ib/II, single-arm, non-randomized, non-blind, multicenter study designed to determine whether Afatinib is effective and safe in patients with locoregionally unresectable and / or metastatic HNSCC with Fanconi Anemia. The main hypothesis, based on p…
Phase 1/2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a smarter scan make liver testing more reliable?
Diagnosis Recruiting nowThis is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 153 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.
Sponsor: Echosens • Aim: Diagnosis
Last updated Aug 07, 2026 00:00 UTC